BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11361797)

  • 1. FDA clearance for ritonavir in children with AIDS.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361797
    [No Abstract]   [Full Text] [Related]  

  • 2. [HIV: to administer protease inhibitors early].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916
    [No Abstract]   [Full Text] [Related]  

  • 3. Ritonavir pediatric study results reported.
    AIDS Patient Care STDS; 1998 Jan; 12(1):63. PubMed ID: 11361889
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination study of Invirase and Norvir starting.
    AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA triple header. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTG 320 trial halted as three-drug arm proves superior.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361796
    [No Abstract]   [Full Text] [Related]  

  • 7. AmFAR extols FDA on rapid approval of two protease inhibitors.
    AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
    [No Abstract]   [Full Text] [Related]  

  • 8. Man of the Year. Hope with an asterisk.
    Lacayo R
    Time; 1996 Dec 30-1997 Jan 6; 148(29):82-5. PubMed ID: 10163846
    [No Abstract]   [Full Text] [Related]  

  • 9. Research study of combination AIDS therapies underway.
    AIDS Patient Care STDS; 1996 Apr; 10(2):132. PubMed ID: 11361697
    [No Abstract]   [Full Text] [Related]  

  • 10. Ritonavir, Abbott protease inhibitor, approved.
    AIDS Treat News; 1996 Mar; (no 243):2-3. PubMed ID: 11363300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitor combination.
    AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361664
    [No Abstract]   [Full Text] [Related]  

  • 12. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA Committee recommends clearance for HIVID combination therapy.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361630
    [No Abstract]   [Full Text] [Related]  

  • 14. Undetectable HIV levels after triple therapy with indinavir.
    AIDS Patient Care STDS; 1997 Jun; 11(3):193-4. PubMed ID: 11361795
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abbott AIDS medicine gets FDA approval earlier than expected.
    AIDS Read; 2000 Oct; 10(10):574. PubMed ID: 11068792
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug companies seek trial participants.
    AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Meeting of the Pediatric Work Group AIDS in Germany (PAAD) on May 8-9, 1998 in Frankfurt/Main].
    Funk M
    Klin Padiatr; 1999; 211(2):96-7. PubMed ID: 10407820
    [No Abstract]   [Full Text] [Related]  

  • 19. Amprenavir approved.
    AIDS Patient Care STDS; 1999 Jul; 13(7):438. PubMed ID: 10870601
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of treatment with nucleoside analogues in subjects with primary genotypic resistance to zidovudine].
    Leal M; Caruz A; Rey C; Lissen E
    Med Clin (Barc); 1996 Nov; 107(19):755. PubMed ID: 9082095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.